NCT04152434View on ClinicalTrials.gov

Treatment of Chronic Migraine With Erenumab Alone or as an Add on Therapy

CompletedOBSERVATIONAL
Enrollment

158

Participants

Timeline

Start Date

April 1, 2019

Primary Completion Date

July 30, 2019

Study Completion Date

August 30, 2019

Conditions
Refractory Chronic Migraine
Interventions
DRUG

Erenumab Auto-Injector

Assess synergy of add on medication to Erenumab

Trial Locations (1)

H2W 1V1

Guy Pierre Boudreau, Montreal

All Listed Sponsors
lead

Clinique des Céphalées de Montréal

OTHER

NCT04152434 - Treatment of Chronic Migraine With Erenumab Alone or as an Add on Therapy | Biotech Hunter | Biotech Hunter